Abstract:Abstract Recently, organoids have been widely used in cancer research. However, cancer organoids have limitation in reflecting physicochemical microenvironments of tumor. In particular, vascular networks not only provide oxygen and nutrients to the tumor, but also play an important role as a channel through which drugs move in cancer. Vascularization occurs in an uncontrollable form and speed in conventional methods. Here, we regulate the directionality of the vascular bed using the surface acoustic waves(SAW) technology by which, vascular cells are locally aligned. Aligned cells exhibited an improved, cell-cell contact enhancing the vascular system maturation in a couple days. Organoids are constructed from gastric cancer patients with four molecular subtypes according to TCGA. Organoids were dissociated into a single cell to make a co-culture spheroid with HUVEC cells. Co-cultured spheroids were formed by adding fibronectin according to the characteristics of the patient sample. The SAW device is built with interdigitated transducer, NiNbO3 substrate, polydimethylsiloxane(PDMS) and coverglass. After putting co-culture spheroids and HUVEC cells mixed with fibrin gel into the device, patterning is performed using surface acoustic waves with shaking in EGM-2 media. After fixing the models, CD31 and F-actin are stained and imaged through immunofluorescent. Immunohistochemistry was performed to confirm the blood vessel cross section. The blood vessels patterned with SAW were well aligned in a straight line, and a lumen structure was formed in a couple days. When co-cultured spheroids were used compared to mono-cultured spheroids, the interaction with external HUVECs was improved, allowing for efficient vascular organism models. As evidence for this, it was confirmed that HUVEC inside the co-cultured spheroid and HUVEC outside were connected through interaction when PKH dyeing was done in a different color. We showed that blood vessels are formed faster and thicker in patterning models than in random models, and interactions with co-cultured spheroids are also high. Through immunofluorescent staining, we found that the number of vascular branches linked to spheroids was higher in the SAW model. In addition, in the H&E results, it was confirmed that the blood vessels were arranged in a line, and that differentiation occurred appropriately to form a tubular structure. In addition, the number of blood formed inside the spheroid was higher. Currently, this model is used to test anti-cancer efficacy using FGFR inhibitors and ramucirumab in FGFR2-amplified patient-derived organoids. An efficient vascularized 3D cancer organoid model was constructed using acoustic waves. Our vascularized 3D cancer organoid research platform will be applied for specific drug screening platform that directly aid the treatment of the specific patients with various drugs including chemoagents, targeted drugs, and immune checkpoints inhibitors. Citation Format: Hyoyoung Kim, Yunam Lee, Byungjun Kang, Un-Jung Yun, Yunjung Choi, So Hui Kim, Hyunki Kim, Hyungsuk Lee, Minkyu Jung. Vascularized 3D cancer organoid research platform using surface acoustic waves [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 159.

Acoustic Droplet Printing Tumor Organoids for Modeling Bladder Tumor Immune Microenvironment within a Week

Acoustic Bioprinting of Patient‐Derived Organoids for Predicting Cancer Therapy Responses

Acoustic Printing of Patient‐Derived Organoids That Preserve Tumor Microenvironment for Personalized Drug Screening

The acoustic droplet printing of functional tumor microenvironments

Acoustofluidic assembly of primary tumor-derived organotypic cell clusters for rapid evaluation of cancer immunotherapy

An Automated Organoid Platform With Inter-Organoid Homogeneity And Inter-Patient Heterogeneity

Patient-derived Bladder Cancer Organoid Model to Predict Sensitivity and Feasibility of Tailored Precision Therapy.

3D bioprinting platform development for high-throughput cancer organoid models construction and drug evaluation

Advanced tumor organoid bioprinting strategy for oncology research

Abstract 4231: A biobank of bladder cancer organoids as a platform for screening new therapeutic approaches

Construction of tumor organoids and their application to cancer research and therapy

Abstract 159: Vascularized 3D cancer organoid research platform using surface acoustic waves

In vitro construction of lung cancer organoids by 3D bioprinting for drug evaluation

Microfluidic Droplets As Structural Templates for Matrigel to Enable 1-Week Large Organoid Modeling

Patient‐derived organoids of bladder cancer recapitulate antigen expression profiles and serve as a personal evaluation model for CAR‐T cells in vitro

Organoids: approaches and utility in cancer research

Abstract 4256: Autologous organoids and T cell co-cultures as a powerful personalized platform for immunotherapy development

Ultra-small Tissue-Compatible Organoid Printer for Rapid and Controllable Modeling of Respiratory Organoids

Abstract LB_B18: Rapid and reproducible scaffold free organoid formation for personalized medicine: Multiomic analysis of in-vitro cancer patient model

The use of organoids in creating immune microenvironments and treating gynecological tumors

Organoid Modeling of the Tumor Immune Microenvironment